Latest News:
Subscribe to the latest in micro-cap news and podcasts, straight to your inbox.
Subscribe Now
Facebook Twitter Instagram Youtube Linkedin Apple Spotify

Featured News

NexTech AR
NexTech AR Reports $6 million in Revenues for its Audited Period- Ended December 31st 2019. Major Growth in AR Trends Seen Accelerating in 2020! (NEXCF)
Read Full Article
About Hemp-Derived CBD
Cannabidiol (CBD) is one of at least 113 active cannabinoids identified in cannabis. It is a major phytocannabinoid, accounting for up to 40% of the plant’s extract.
Read More
Remedi – CBD Professionals you Can Trust
The team of Remedi is a collaboration project of hemp and CBD professionals.
Read More
Pressure BioSciences' New CBD Technology
Pressure Biosciences unveils new CBD beverage infusing technology
Watch Video

Hot Stocks of the Day

 
Hot Stocks of the Day by TradingView

Latest News

SANUWAVE Health Reports Full Year 2019 Financial Results
BioTech News 

SANUWAVE Health Reports Full Year 2019 Financial Results

Stock Day Media Comments Off on SANUWAVE Health Reports Full Year 2019 Financial Results

COVID-19 Related Business Update SUWANEE, GA, March 31, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results

BioCorRx Provides Business Update; Pivotal GLP Study of BICX102 Uninterrupted by COVID-19 Pandemic
BioTech 

BioCorRx Provides Business Update; Pivotal GLP Study of BICX102 Uninterrupted by COVID-19 Pandemic

Stock Day Media Comments Off on BioCorRx Provides Business Update; Pivotal GLP Study of BICX102 Uninterrupted by COVID-19 Pandemic
Bioxytran Releases Details on a Novel Carbohydrate Galectin Inhibitor designed to Eliminate COVID-19 in Patients
BioTech 

Bioxytran Releases Details on a Novel Carbohydrate Galectin Inhibitor designed to Eliminate COVID-19 in Patients

Stock Day Media Comments Off on Bioxytran Releases Details on a Novel Carbohydrate Galectin Inhibitor designed to Eliminate COVID-19 in Patients
CytoDyn Completes Non-dilutive $15 Million Convertible Note Financing with Conversion Rate at $4.50 Per Share without Warrants
BioTech News 

CytoDyn Completes Non-dilutive $15 Million Convertible Note Financing with Conversion Rate at $4.50 Per Share without Warrants

Stock Day Media Comments Off on CytoDyn Completes Non-dilutive $15 Million Convertible Note Financing with Conversion Rate at $4.50 Per Share without Warrants

Cannabis

The Green Organic Dutchman Receives Health Canada Licence Amendment for its Ancaster Processing Facility
Cannabis 

The Green Organic Dutchman Receives Health Canada Licence Amendment for its Ancaster Processing Facility

Stock Day Media Comments Off on The Green Organic Dutchman Receives Health Canada Licence Amendment for its Ancaster Processing Facility

TGOD’s Ancaster site now fully licensed Enables automation of several processes Reduces costs and further accelerates production TORONTO, March 30,

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Completes Acquisition of Oncology Research and Development Company Sapphire Biotech, Inc.
BioTech Cannabis 

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Completes Acquisition of Oncology Research and Development Company Sapphire Biotech, Inc.

Stock Day Media Comments Off on Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Completes Acquisition of Oncology Research and Development Company Sapphire Biotech, Inc.
Tauriga Sciences, Inc. Files Provisional U.S. Patent Application Covering its Pharmaceutical Grade Version of Tauri-Gum (TPTW)
BioTech Cannabis 

Tauriga Sciences, Inc. Files Provisional U.S. Patent Application Covering its Pharmaceutical Grade Version of Tauri-Gum (TPTW)

Stock Day Media Comments Off on Tauriga Sciences, Inc. Files Provisional U.S. Patent Application Covering its Pharmaceutical Grade Version of Tauri-Gum (TPTW)
James E. Wagner Cultivation Receives First Purchase Order From the Ontario Cannabis Retail Corporation
Cannabis 

James E. Wagner Cultivation Receives First Purchase Order From the Ontario Cannabis Retail Corporation

Stock Day Media Comments Off on James E. Wagner Cultivation Receives First Purchase Order From the Ontario Cannabis Retail Corporation

Energy

First Cobalt Produces Battery Grade Cobalt Sulfate
Energy 

First Cobalt Produces Battery Grade Cobalt Sulfate

Stock Day Media Comments Off on First Cobalt Produces Battery Grade Cobalt Sulfate

TORONTO, March 30, 2020 TORONTO, March 30, 2020 /CNW/ – First Cobalt Corp. (TSX-V:FCC, OTCQX:FTSSF) (the “Company”) today announced it once again produced a

H/Cell Energy Obtains Contract to Equip Coronavirus Tents
Energy 

H/Cell Energy Obtains Contract to Equip Coronavirus Tents

Stock Day Media Comments Off on H/Cell Energy Obtains Contract to Equip Coronavirus Tents
Amazing Energy Oil and Gas, Co Joins us on the Stock Day Podcast (AMAZ) February, 2020
Energy News Radio Interviews 

Amazing Energy Oil and Gas, Co Joins us on the Stock Day Podcast (AMAZ) February, 2020

Stock Day Media Comments Off on Amazing Energy Oil and Gas, Co Joins us on the Stock Day Podcast (AMAZ) February, 2020
IsoEnergy Finalizes Uranium Target Areas for Winter Drilling; Notes Increasing Uranium Price in Spot Market
Energy 

IsoEnergy Finalizes Uranium Target Areas for Winter Drilling; Notes Increasing Uranium Price in Spot Market

Stock Day Media Comments Off on IsoEnergy Finalizes Uranium Target Areas for Winter Drilling; Notes Increasing Uranium Price in Spot Market

Mining

RNC Announces Strong Fourth Quarter Results Including Gold Production of 26,874 oz, Adjusted Earnings(2) of $14 million, 2H19 AISC(1),(2) Guidance Beat and No Change to 2020 guidance
Mining 

RNC Announces Strong Fourth Quarter Results Including Gold Production of 26,874 oz, Adjusted Earnings(2) of $14 million, 2H19 AISC(1),(2) Guidance Beat and No Change to 2020 guidance

Stock Day Media Comments Off on RNC Announces Strong Fourth Quarter Results Including Gold Production of 26,874 oz, Adjusted Earnings(2) of $14 million, 2H19 AISC(1),(2) Guidance Beat and No Change to 2020 guidance

RNC will host a call/webcast on March 26, 2020 at 10:00 a.m. (Eastern Time) to discuss the fourth quarter results.

Drilling at Las Conchitas Extends Near Surface, High-Grade Gold Mineralization Across Multiple Intercepts at the Bayacun Zone, Highlighted by 84.64 g/t Gold Over 1.6 Meters
Mining 

Drilling at Las Conchitas Extends Near Surface, High-Grade Gold Mineralization Across Multiple Intercepts at the Bayacun Zone, Highlighted by 84.64 g/t Gold Over 1.6 Meters

Stock Day Media Comments Off on Drilling at Las Conchitas Extends Near Surface, High-Grade Gold Mineralization Across Multiple Intercepts at the Bayacun Zone, Highlighted by 84.64 g/t Gold Over 1.6 Meters
Amex Reports Numerous Gold Intercepts on Grey Cat and Gratien Zones (AMXEF)
Mining 

Amex Reports Numerous Gold Intercepts on Grey Cat and Gratien Zones (AMXEF)

Stock Day Media Comments Off on Amex Reports Numerous Gold Intercepts on Grey Cat and Gratien Zones (AMXEF)
GoGold Intersects 18.8m Near Surface of 255 g/t Silver Equivalent at Los Ricos South Project (GLGDF)
Mining 

GoGold Intersects 18.8m Near Surface of 255 g/t Silver Equivalent at Los Ricos South Project (GLGDF)

Stock Day Media Comments Off on GoGold Intersects 18.8m Near Surface of 255 g/t Silver Equivalent at Los Ricos South Project (GLGDF)

Biotech

SANUWAVE Health Reports Full Year 2019 Financial Results
BioTech News 

SANUWAVE Health Reports Full Year 2019 Financial Results

Stock Day Media Comments Off on SANUWAVE Health Reports Full Year 2019 Financial Results

COVID-19 Related Business Update SUWANEE, GA, March 31, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — SANUWAVE Health, Inc. (OTCQB: SNWV) reported financial results

BioCorRx Provides Business Update; Pivotal GLP Study of BICX102 Uninterrupted by COVID-19 Pandemic
BioTech 

BioCorRx Provides Business Update; Pivotal GLP Study of BICX102 Uninterrupted by COVID-19 Pandemic

Stock Day Media Comments Off on BioCorRx Provides Business Update; Pivotal GLP Study of BICX102 Uninterrupted by COVID-19 Pandemic
Bioxytran Releases Details on a Novel Carbohydrate Galectin Inhibitor designed to Eliminate COVID-19 in Patients
BioTech 

Bioxytran Releases Details on a Novel Carbohydrate Galectin Inhibitor designed to Eliminate COVID-19 in Patients

Stock Day Media Comments Off on Bioxytran Releases Details on a Novel Carbohydrate Galectin Inhibitor designed to Eliminate COVID-19 in Patients
CytoDyn Completes Non-dilutive $15 Million Convertible Note Financing with Conversion Rate at $4.50 Per Share without Warrants
BioTech News 

CytoDyn Completes Non-dilutive $15 Million Convertible Note Financing with Conversion Rate at $4.50 Per Share without Warrants

Stock Day Media Comments Off on CytoDyn Completes Non-dilutive $15 Million Convertible Note Financing with Conversion Rate at $4.50 Per Share without Warrants